Intrarenal Administration of Molsidomine, a Molecule Releasing Nitric Oxide, Reduces Renal Ischemia-Reperfusion Injury in Rats
Open Access
- 1 October 2004
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 4 (10), 1605-1613
- https://doi.org/10.1111/j.1600-6143.2004.00560.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Acute Renal Failure: Is Nitric Oxide the Bad Guy?Antioxidants and Redox Signaling, 2002
- Endoglin Upregulation During Experimental Renal Interstitial Fibrosis in MiceHypertension, 2002
- Promising effects of ischemic preconditioning in renal transplantationKidney International, 2002
- Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.JCI Insight, 1995
- THE IMPACT OF THE QUALITY OF INITIAL GRAFT FUNCTION ON CADAVER KIDNEY TRANSPLANTS1,2Transplantation, 1994
- Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase.JCI Insight, 1992
- Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusionCritical Care Medicine, 1991
- On the Mechanism of NO Release from SydnoniminesJournal of Cardiovascular Pharmacology, 1989
- Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure.JCI Insight, 1988
- Protective effects of hydralazine in a renal ischemia model in the ratLife Sciences, 1987